Cargando…

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Ryan, J, Tivnan, A, Fay, J, Bryan, K, Meehan, M, Creevey, L, Lynch, J, Bray, I M, O'Meara, A, Tracey, L, Davidoff, A M, Stallings, R L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461175/ http://dx.doi.org/10.1038/bjc.2012.425

Ejemplares similares

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
por: Tivnan, Amanda, et al.
Publicado: (2011)

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
por: Foley, Niamh H, et al.
Publicado: (2010)

MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
por: Creevey, Laura, et al.
Publicado: (2013)

Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19
por: Quintero, Ana M, et al.
Publicado: (2022)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

Neuroblastoma in monozygotic twins – a case of probable twin to twin metastasis
por: Anderson, J, et al.
Publicado: (2002)

Corrigendum to ‘Tiered restrictions for COVID-19 in England: Knowledge, motivation and self-reported behaviour’ [Public Health 204 (2022) 33–39]
por: Smith, L.E., et al.
Publicado: (2022)

Corrigendum to: UNC13B variants associated with partial epilepsy with favourable outcome
Publicado: (2021)

Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD(2) Coated Nanoparticles
por: Tivnan, Amanda, et al.
Publicado: (2012)

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
por: Rocha, C R R, et al.
Publicado: (2015)

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
por: O'Brien, P M, et al.
Publicado: (2008)

Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462]
por: Castañeda, A., et al.
Publicado: (2022)

Modulation of Neuroblastoma Disease Pathogenesis By An Extensive Network of Epigenetically Regulated MicroRNAs
por: Das, Sudipto, et al.
Publicado: (2012)

Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981–2000: a population-based study
por: Schroeder, H, et al.
Publicado: (2009)

Divergent functional isoforms drive niche specialisation for nutrient acquisition and use in rumen microbiome
por: Rubino, Francesco, et al.
Publicado: (2017)

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
por: Koizumi, W, et al.
Publicado: (2014)

Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
por: Bray, Isabella, et al.
Publicado: (2009)

Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]
Publicado: (2014)

Expressional alterations in functional ultra-conserved non-coding rnas in response to all-trans retinoic acid - induced differentiation in neuroblastoma cells
por: Watters, Karen M, et al.
Publicado: (2013)

High TNF-α and/or p38MAPK expression predicts a favourable prognosis in patients with T1N0M0 hepatocellular carcinoma: An immunohistochemical study
por: Zhang, Mao, et al.
Publicado: (2019)

Correction to: Ocean warming favours a northern Argyrosomus species over its southern congener, whereas preliminary metabolic evidence suggests that hybridization may promote their adaptation
Publicado: (2023)

Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin
por: Meczes, E L, et al.
Publicado: (2002)

MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
por: Wang, H, et al.
Publicado: (2014)

The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts
por: Li, Chao, et al.
Publicado: (2022)

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
por: Vega, Francisco M., et al.
Publicado: (2020)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
por: Mohlin, Sofie, et al.
Publicado: (2020)

Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
por: Ross-Adams, H., et al.
Publicado: (2017)

[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
por: Račkauskas, Rokas, et al.
Publicado: (2023)

Metastasis Suppressor microRNA-335 Targets the Formin Family of Actin Nucleators
por: Lynch, Jennifer, et al.
Publicado: (2013)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: Kataoka, Junro, et al.
Publicado: (2017)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours
por: Rijlaarsdam, M A, et al.
Publicado: (2012)

Awareness of prostate cancer among patients and the general public: results of an international survey
por: Fitzpatrick, J M, et al.
Publicado: (2009)

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide
por: Astrup, A, et al.
Publicado: (2012)

Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis
por: Manton, K J, et al.
Publicado: (2015)

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
por: Manton, D J, et al.
Publicado: (2006)

The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro.
por: Armour, A., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_4f9ddtae2lr1h1sfa75dt34go0